Stocks Health care FENC
NASDAQ · Health careFennec Pharmaceuticals Inc. (FENC)
Fennec Pharmaceuticals Inc. brought in $59.2M of revenue over the twelve months to June 30, 2026, up 77.8% from a year earlier. It posted a net loss of $3.3M. At June 30, 2026 it held $41.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Fennec Pharmaceuticals Inc. does
Fennec Pharmaceuticals Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker FENC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $44.6M | -$9.7M | -$0.34 | n/a |
| 2024 | $47.5M | -$436K | -$0.02 | n/a |
| 2023 | $23.8M | -$16M | -$0.60 | n/a |
| 2022 | $1.8M | -$23.7M | -$0.90 | n/a |
| 2021 | n/a | -$17.3M | -$0.67 | n/a |
| 2020 | $170K | -$18.1M | -$0.76 | n/a |
Latest SEC filings
What Fennec Pharmaceuticals Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 17, 2026Other event 8-K
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- June 11, 2026
- June 10, 2026
- May 22, 2026Other event 8-K
- May 18, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Questions about FENC
What does Fennec Pharmaceuticals Inc. do?
Fennec Pharmaceuticals Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker FENC.
Is Fennec Pharmaceuticals Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $3.3M on revenue of $59.2M.
How much revenue does Fennec Pharmaceuticals Inc. make?
Over the twelve months to June 30, 2026 Fennec Pharmaceuticals Inc. reported revenue of $59.2M. That is 77.8% more than a year earlier.
When did Fennec Pharmaceuticals Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 17, 2026.
Similar companies
Follow FENC
Get an email when Fennec Pharmaceuticals Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow FENC: get an email when it filesWhere the numbers come from
Financial figures are the values Fennec Pharmaceuticals Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.